• intloko_banner_01

I-tirzpatide ye-tirzpatide ucocekile of Sulty i-99% ye-Peptrade Powder TR 10MG i-15mg i-20mg 20MG 20MG 30MG kwi-vial yeswekile yegazi / iswekile

Inkcazo emfutshane:

Igama: i-tirzpatide yenja

Ucoceko: I-99%

Izibonelelo: Ukunyanga isifo seswekile, ukuphucula ulawulo lweswekile yegazi

Ulawulo: Inaliti ye-subcutaneous

Ubungakanani: I-10mg, i-15mg, i-20mg, 30mg

Amanzi: I-3.0%

Inkangeleko: i-LYY LYILDERP


Iinkcukacha zemveliso

Iimpawu zeMveliso

Iinkcukacha zemveliso

Igama Inja ye-tirzetide
Ubunyulu I-99%
Imbonakalo Umgubo omhlophe
Ulawulo Inaliti engaphantsi kwenaliti
Ubungakanani I-10mg, i-15mg, i-20mg, 30mg
Amanzi I-3.0%
Izibonelelo Ukunyanga iswekile, ukuphucula ulawulo lweswekile yegazi

Inkcazo

I-tirzepatide yi-Novel Glucose-ixhomekeke kwi-Inpecinase ye-Inpecappic / i-Glucagon-Agppide 1 Ngamaqhekeza ogcinweyo kunye nokutyeba kakhulu kunye ne-steatohepatitititis enxilisayo. Inkqubo yeSigaba se-3 yeKlinikhi yeKlinikhi yeKlinikhi ye-1-5 yenzelwe ukuvavanya ukusebenza kunye nokhuseleko lwe-tirzhayi nge veki nganye, njengoko unyango lwe-5, 10 kunye nonyango lwabantu oluneswekile. Ukusetyenziswa kwe-tirzpatide kwizifundo zeklinikhi kwanxulunyaniswa nokuncitshiswa kwe-hemoglobin eguqulweyo (-1.87 ukuya kuthi ga kwi-DoLMEABOBEABEABOLICS EBALULEKILEYO, NE-MOL) kunye noxinzelelo lwe-visceral kunye nokujikeleza kwezinto ezijikelezayo. UTirzepatide wanyamezeleka kakuhle, ngomngcipheko ophantsi we-hypoglycaemia xa isetyenziswa ngaphandle kwe-insulin okanye i-insulin camgoes kwaye ibonise iprofayili efanayo yokhuseleko kwi-GLP-1 ye-Agonist Agonist Agonist. Ngokuhambelana, ubungqina obuvela kula mvavanyo zeklinikhi lucebisa ukuba iTirzeatide ibonelela ngamathuba amatsha okuthotyelwa kwe-hemoglobin ekhutshiweyo ye-hemoglobin kunye nobunzima bomzimba kubantu abadala.


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo apha kwaye uthumele kuthi